Sotalol Global Buyers List: Key Importers, Pharmaceutical Distributors & Procurement Guide

Sotalol hydrochloride is an essential class II and III antiarrhythmic agent prescribed for life-threatening ventricular arrhythmias and for maintaining normal sinus rhythm in patients with atrial fibrillation or atrial flutter. The API is classified under ATC code C07AA07, covering non‑selective beta‑blocking agents. With a robust pipeline of generics, a growing prevalence of cardiovascular diseases, and evolving supply chain dynamics, understanding the global buyer landscape is essential for any pharmaceutical business. This guide consolidates market intelligence, identifies key buyers across regions, and offers actionable procurement strategies.

1. Global Market Overview

The global sotalol market has been experiencing steady expansion. The sotalol hydrochloride market was valued at approximately USD 700 million in 2024, with projections to grow from USD 800 million in 2025 to USD 1,200 million by 2035. Another research indicates even stronger momentum, forecasting the market to reach USD 12.11 billion by 2033 at a compound annual growth rate (CAGR) of 10.5%.

North America and Europe remain mature markets, while the Asia‑Pacific region, led by China, holds a leading position in production and consumption due to robust domestic demand and a strong manufacturing base. The Middle East and Africa are also showing steady growth, driven by improving healthcare facilities and rising cardiovascular disease prevalence. These regional dynamics directly influence where the most active buyers are located.

2. Global Buyers and Importers List

Based on publicly available trade data, regulatory filings, and procurement records, the following sections categorize key buyers and importers of sotalol hydrochloride by region.

2.1 North America

United States

The U.S. market is the largest consumer of sotalol, driven by a high prevalence of cardiac arrhythmias and a well‑established generic pharmaceutical sector. Key buyers include:

  • Teva Pharmaceuticals USA, Inc. – One of the largest generic drug marketers in the U.S., actively involved in sotalol procurement.
  • Apotex Corp. – A major Canadian‑based generic manufacturer with significant U.S. operations.
  • Aurobindo Pharma USA – The U.S. arm of the Indian generic giant.
  • Sun Pharmaceutical Industries – A leading Indian generic drug maker with a strong U.S. presence.
  • Epic Pharma LLC – A specialty generic manufacturer.
  • Upsher‑Smith Laboratories – A U.S.‑based company known for branded and generic products.
  • Golden State Medical Supply, Inc. – A prominent repackager and distributor.
  • Marlex Pharmaceuticals, Inc. – Another key repackager and distributor.
  • AiPing Pharmaceutical, Inc. – Known for its SORINE brand of sotalol hydrochloride tablets.
  • AltaThera Pharmaceuticals LLC – Holds the NDA for Sotalol Hydrochloride and markets branded formulations.
  • Oxford Pharmaceuticals – A specialty generic pharmaceutical buyer and supplier.
  • Watson Laboratories, Inc. – A subsidiary of Teva, involved in generic production.
  • Legacy Pharma USA, Inc. – Listed as a packager in FDA records.
  • Aidarex Pharmaceuticals LLC – Another packager registered with the FDA.

The U.S. federal government, through the Department of Veterans Affairs (VA), also issues tenders for sotalol. A 2025 tender listed Marlex Pharmaceuticals as a supplier to the VA system.

Canada

Although trade data is less granular, Canadian importers are often represented by the global arms of companies like Apotex, which operates a distribution center in Plainfield, Indiana, and supplies to Canada. Regulatory documents also list Canadian distributors affiliated with Bristol‑Myers Squibb and Teva.

2.2 Europe

The European pharmaceutical market is highly consolidated, with many buyers operating through centralized procurement or public tenders.

Germany

Germany is the largest European consumer of sotalol. Buyers include:

  • Bayer HealthCare – A major originator and brand holder, actively involved in sotalol distribution.
  • HEXAL AG – A Novartis subsidiary that markets SOTAHEXAL, a sotalol brand, in Germany.
  • Aurobindo Pharma B.V. – The Dutch subsidiary of Aurobindo, serving the European market.

United Kingdom

Buyers in the UK are often tied to the National Health Service (NHS) procurement framework. The Medicines and Healthcare products Regulatory Agency (MHRA) lists sotalol 80 mg and 160 mg tablets as indicated for ventricular tachyarrhythmias, with supply handled by major wholesalers such as Alliance Healthcare, AAH Pharmaceuticals, and Lexon UK.

France, Italy, and the Benelux

The brand SOTALEX is authorized in France, Germany, and Italy. Public procurement in these countries is often conducted through regional tenders. For instance, a 2025 tender by the Government of Malta called for the supply of sotalol hydrochloride 80 mg tablets.

Latvia

Latvia’s Medicinal Product Register lists Sotagamma 80 mg tablets as a registered formulation, with availability information provided by local wholesalers. Wholesalers in the Baltic states are therefore key buyers in the region.

2.3 Asia-Pacific

The Asia-Pacific region is the fastest‑growing market for sotalol, driven by rising cardiovascular disease rates and expanding healthcare access.

China

China is both a major manufacturer and a significant consumer. Key buyers include:

  • Zhejiang Xianju Pharmaceutical Co., Ltd. – A leading API manufacturer and buyer of intermediates.
  • Shaanxi Hanjiang Pharmaceutical Group – An active manufacturer and buyer.
  • Newstar Chem Enterprise Ltd. – A technology‑based buyer with a presence in Zhejiang, Jiangsu, and Shandong provinces.
  • Lunan Better Pharmaceutical Co., Ltd. – A Chinese pharmaceutical company with active sotalol purchasing records.

Chinese procurement is often conducted through provincial tenders and hospital group purchasing organizations (GPOs).

India

India is one of the world’s largest producers of generic sotalol, but it is also a significant importer, especially of advanced formulations and reference products. Key Indian buyers include:

  • Samarth Pharma Pvt. Ltd. – A Mumbai‑based manufacturer and importer.
  • Cipla Limited – A global giant that both manufactures and imports sotalol as part of its portfolio.
  • Dheer Healthcare Private Limited – A supplier and third‑party manufacturer listed as an importer of sotalol tablets.
  • Yashdeep Pharma & Nutraceuticals – A Mumbai‑based retailer and importer.
  • Ernest Pharmaceutical Pvt Ltd (UK subsidiary) – An exporter from India and a source for Solet tablets.
  • GNH India – A pharmaceutical distributor that imports sotalol for resale.

India’s trade data indicates that sotalol is imported under HS code 30049033, with many shipments coming from Canada and Europe.

Japan, South Korea, and Australia

  • Japan: The brand SOTACOR is authorized in Japan, with procurement typically managed through wholesalers such as Alfresa Corporation and Toho Pharmaceutical.
  • Australia: The Therapeutic Goods Administration (TGA) lists sotalol tablets as registered products. Key buyers include Chemmart pharmacies and major hospital networks.
  • New Zealand: Pharmac, the government agency, manages sotalol procurement. A 2025 supply issue was resolved through wholesaler distribution.

2.4 Middle East and Africa

The MEA region is a growing market for sotalol, with procurement often managed through government tenders and major hospital groups.

  • Israel: Several sotalol brands are registered, and buyers include Teva Israel and major hospital pharmacies.
  • South Africa: The brand SOTAHEXAL is authorized in South Africa, with procurement typically handled by large wholesalers such as Dis‑Chem Pharmacies and Clicks Group.
  • Brazil: The brand SOTACOR is authorized in Brazil, with buyers including the Brazilian Ministry of Health and private hospital networks.
  • Other Markets: Manufacturers like Bayer, GSK, and Bristol‑Myers Squibb have regional distribution hubs in the UAE and Saudi Arabia, serving as key buyers for the broader region.

3. How to Identify and Engage Sotalol Buyers

For companies looking to enter the sotalol supply chain, the following data sources and methods are most effective:

  • Pharmaceutical Trade Data Platforms: Volza has recorded 118 global buyers of sotalol hydrochloride across 35 countries. Platforms like Volza provide shipment‑level data, including importer names, origins, and destinations. Pharmacompass offers lists of API manufacturers, exporters, and distributors, searchable by GMP, DMF, CEP, and other certifications.
  • Drug Regulatory Databases: The U.S. FDA’s NDA/ANDA listings (e.g., NDA 077070, 075429, 077238) list all approved generic manufacturers. Similar registers in Europe, India, and China provide direct leads on authorized buyers.
  • Government Tender Portals: Websites like etenders.gov.mt (Malta), indiantenders.in (India), and russiatenders.com (Russia) frequently publish sotalol procurement notices. A recent 2026 tender in Russia by the Ministry of Property Relations and State Orders of the Tambov Region sought sotalol supplies.
  • B2B Platforms: Alibaba has published a detailed guide for identifying top‑tier sotalol hydrochloride API suppliers in China, recommending priorities such as suppliers in Guangdong Province with high ratings. PharmaOffer allows users to filter API and formulation suppliers by certificate, price, and location.

4. Key Regulatory and Quality Compliance

Before engaging with any buyer, ensure that your supply chain meets the necessary regulatory standards:

  • Drug Master Files (DMF): Sotalol hydrochloride has numerous DMF entries in the U.S. and other regions.
  • Certificate of Suitability (CEP): European buyers typically require a valid CEP. Platforms like PharmaCompass allow you to search specifically for manufacturers with CEP.
  • Good Manufacturing Practice (GMP): All major buyers expect GMP‑certified production facilities.
  • Patent and Exclusivity Status: Sotalol has multiple NDAs and generics; understanding patent expirations is critical.

5. Strategic Sourcing and Procurement Recommendations

For procurement managers and suppliers aiming to build a resilient, compliant supply chain for sotalol hydrochloride, the following strategies are recommended:

  • Prioritize Verified Suppliers: Focus on suppliers with verifiable quality data and regulatory filings (DMF, CEP, GMP).
  • Leverage Digital Procurement Platforms: Use e‑procurement systems to monitor global tenders and automate bid submissions.
  • Maintain Safety Stock: Recent supply chain disruptions, such as the 2025 shortage of sotalol 80 mg tablets in New Zealand due to API procurement delays, highlight the importance of maintaining safety stock.
  • Build Regional Partnerships: Engage with local distributors in key markets (e.g., Dis‑Chem in South Africa, Alfresa in Japan) to navigate regulatory hurdles.
  • Monitor Regulatory Changes: Stay updated on tariff measures, trade agreements, and import policies that may affect pricing and availability.

ULTRA INTERNATIONAL
TEVA PHARMACEUTICAL USA INC
JUAN DANIEL ZAPATA ZAPATA
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORYPRIVATE LI
PIRAMAL PHARMA LIMITED
TEVA PHARMACEUTICALS USA INC
ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
NEULAND LABORATORIES LTD
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
IMSIPHARMA LIMITADA
STRIDES PHARMA SCIENCE LIMITED
BEXIMCO PHARMACEUTICALS LIMITED
SIERRA S A
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
ARROW GENERIQUES SAS
NEULAND LABORATORIES LIMITED
STALLION LABORATORIES PVT LTD
ABBOTT LABORATUARLARI ITHALAT IHRACAT VE TICARET LIMITED SIRKETI
AUROBINDO PHARMA LTD
BEXIMCO PHARMACEUTICALS PLC
CIPLA LIMITED
CM STAR CORP
CM STAR CORPORATION
GENERICS AFRICA LIMITED
GLOBELINE INTERNATIONAL SHIPPING IN
GUARDIAN HEALTH LIMITED
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE L
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE LIMITED
UNIMED UNIHEALTH PHARMACEUTICALS
ТОВ ІНСТИТУТ БІОХІМІЧНИХ ТЕХНОЛОГІЙ 03179 М КИЇВ ПР ПЕРЕМОГИ 123
AUROBINDO USA
AZELIS RUS LLC
AZELIS RUSSIA LLC
AZELIS TR KIMYA ENDUSTRISI URUNLERI ITHALAT IHRACAT TICARET VE SANAYI ANONIM SIRKETI
C A PHARMACEUTICALS LTD
CANONPHARMA PRODUCTION
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
DSV AIR SEA INC
FIRST PHARMACY UGANDA LIMITED
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
M S WERRICK PHARAMACEUTICALS
NOVARTIS NEVA LLC
PHARMA MART LIMITED
SIGMA ALDRICH QUIMICA S DE RL DE CV
WERRICK PHARMACEUTICALS
ООО ОЗОН
ТОО NOVA CHEMICAL
ALPHA CHEM SA DE CV
ANALYTICA CHEMIE INC
APL SWIFT SERVICES MALTA LTD
APOTEX PTY LTD
AUROLOGISTICS LLC
BIONIFY BIOSCIENCE OPC PRIVATE LIMITED
CANONPHARMA PRODUCTION CJSC
CÔNG TY CỔ PHẦN DƯỢC PHẨM OPV
CÔNG TY CỔ PHẦN DƯỢC PHẨM PHƯƠNG ĐÔNG
CÔNG TY TNHH KHOA HỌC HỢP NHẤT
CÔNG TY TNHH LIÊN DOANH STELLAPHARM CHI NHÁNH 1
CÔNG TY TNHH MTV NOVALAB
DSV AIR SEA INC 440 MCCLELLAN
FEROZSONS LABORATORIES LIMITED
FEROZSONS LABORATORIES LTD
FLAMINGO PHARMACEUTICALS LTD
GBS LIFESCIENCES LLP
GENOME PHARMACEUTICALS PVT LIMITED
GENOME PHARMACEUTICALS PVT LTD
INTERNATIONAL CONSULTING NETWORK SAS
KRISHGEN BIOSYSTEMS PRIVATE LIMITED
MANUEL SANCHEZ
MERTON CAPITAL LIMITED
MNBF FOR A HEALTHY GENERATION
O HERVANARIO S DE RL
PHARMAFFILIATES ANALYTICS AND SYNTHETICS PRIVATE L
SABIHA RESEARCH AND DEVELOPMENT LLP
SANDOZ PTY LTD
SAYNS LLC
SIMSON PHARMA LIMITED
TOWNCARE PHARMACY LIMITED
ULTRA BIO INSTRUMENTS PRIVATE LIMITED
VARGAS BRISE O MARISOL
VEEDA CLINICAL RESEARCH LIMITED
МНБФ SOGLOM AVLOD UCHUN
ТОВ АФІТРЕЙД 07301 КИЇВСЬКА ОБЛ ВИШГОРОДСЬКИЙ РАЙОН М ВИШГОРОД ВУЛ БОРИСО ГЛІ
ТОВ АФІТРЕЙД 07301 КИЇВСЬКА ОБЛ ВИШГОРОДСЬКИЙ РАЙОН М ВИШГОРОД ВУЛ ВАТУТІНА Б
ТОО SMARTCHEM

6. Conclusion

The global sotalol market offers significant opportunities for both buyers and suppliers. By leveraging the buyer and importer list above, utilizing trade data platforms like Volza and Pharmacompass, and staying compliant with regulatory standards, pharmaceutical businesses can effectively navigate this growing market. As demand for antiarrhythmic drugs continues to rise, the role of informed procurement and reliable supply chains will only become more critical.

For ongoing market intelligence, regularly consult the FDA NDA database, European Medicines Agency product registers, and global trade data platforms. With the right partners and information, success in the sotalol hydrochloride market is well within reach.

error: Content is protected !!